A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria

Journal of Pharmaceutical Sciences

Volumn 103, Issue 7, 2014, Pages 2022-2032

  De Barros, João M S ^a   Scherer, Timothy ^a   Charalampopoulos, Dimitrios ^a   Khutoryanskiy, Vitaliy V ^a   Edwards, Alexander D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

dissolution; drying; enteric delivery; oral drug delivery; polymer film; polymers; probiotics; vaccine delivery

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; LIVE VACCINE; POLYMER; PROBIOTIC AGENT; ACRYLIC ACID RESIN; BACTERIAL VACCINE; CELLULOSE; DRUG CARRIER; EUDRAGIT L100-55;

ARTICLE; CELL COUNTING; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; FILM; INTESTINE; STOMACH JUICE; ANALOGS AND DERIVATIVES; BIFIDOBACTERIUM; BIOLOGICAL MODEL; CHEMISTRY; DRUG RELEASE; DRUG STABILITY; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PH;

ACRYLIC RESINS; ADMINISTRATION, ORAL; BACTERIAL VACCINES; BIFIDOBACTERIUM; CELLULOSE; DRUG CARRIERS; DRUG LIBERATION; DRUG STABILITY; GASTRIC JUICE; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PROBIOTICS; VACCINES, ATTENUATED;

EID: 84902954439     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23997     Document Type: Article

References (42)

1. Levine MM,. 2006. Enteric infections and the vaccines to counter them: Future directions. Vaccine 24 (18): 3865-3873.
2. Medina E, Guzmán CA,. 2001. Use of live bacterial vaccine vectors for antigen delivery: Potential and limitations. Vaccine 19 (13-14): 1573-1580. (Pubitemid 32175714)
3. Bron PA, van Baarlen P, Kleerebezem M,. 2012. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10 (1): 66-78.
4. Guarner F, Malagelada J-R,. 2003. Gut flora in health and disease. The Lancet 361 (9356): 512-519. (Pubitemid 36173720)
5. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E,. 2003. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21 (7): 785-789. (Pubitemid 36791397)
6. Duan F, Curtis KL, March JC,. 2008. Secretion of insulinotropic proteins by commensal bacteria: Rewiring the gut to treat diabetes. Appl Environ Microbiol 74 (23): 7437-7438. (Pubitemid 352773587)
7. Kantele A, Arvilommi H, Kantele JM, Rintala L, Makela PH,. 1991. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb Pathog 10 (2): 117-126.
8. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Müller M, Blander JM,. 2011. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474 (7351): 385-389.
9. Adams CA,. 2010. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr Res Rev 23 (1): 37-46.
10. Huyghebaert N, Vermeire A, Remon JP,. 2004. Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules. Eur J Pharm Sci 21 (5): 617-623. (Pubitemid 38447143)
11. Lecomte F, Siepmann J, Walther M, MacRae R, Bodmeier R,. 2003. Blends of enteric and GIT-insoluble polymers used for film coating: Physicochemical characterization and drug release patterns. J Control Release 89 (3): 457-471. (Pubitemid 36555904)
12. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R,. 2008. Polymer blends for controlled release coatings. J Control Release 125 (1): 1-15. (Pubitemid 350198680)
13. Edwards AD, Slater NKH,. 2008. Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance. Vaccine 26 (45): 5675-5678.
14. Edwards AD, Slater NKH,. 2009. Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins. Vaccine 27 (29): 3897-3903.
15. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R,. 2005. Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size. J Control Release 105 (3): 226-239. (Pubitemid 40941988)
16. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R,. 2004. Polymer blends used for the aqueous coating of solid dosage forms: Importance of the type of plasticizer. J Control Release 99 (1): 1-13. (Pubitemid 39165729)
17. Stadler M, Viernstein H,. 2003. Optimization of a formulation containing viable lactic acid bacteria. Int J Pharm 256 (1-2): 117-122. (Pubitemid 36412144)
18. Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S,. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17 Suppl 2: S22-S27. (Pubitemid 29457532)
19. Huyghebaert N, Vermeire A, Neirynck S, Steidler L, Remaut E, Remon JP,. 2005. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. Eur J Pharm Biopharm 60 (3): 349-359. (Pubitemid 40922832)
20. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV,. 2011. Production and evaluation of dry alginate-chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromolecules 12 (7): 2834-2840.
21. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV,. 2012. Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162 (1): 56-67.
22. Crowe JH, Hoekstra FA, Crowe LM,. 1992. Anhydrobiosis. Annu Rev Physiol 54 (1): 579-599.
23. Ohtake S, Wang YJ,. 2011. Trehalose: Current use and future applications. J Pharm Sci 100 (6): 2020-2053.
24. Santivarangkna C, Kulozik U, Foerst P,. 2007. Alternative drying processes for the industrial preservation of lactic acid starter cultures. Biotechnol Prog 23 (2): 302-315. (Pubitemid 46626302)
25. Morgan C, Herman N, White P, Vesey G,. 2006. Preservation of micro-organisms by drying; a review. J Microbiol Methods 66 (2): 183-193. (Pubitemid 43903039)
26. Nindo C, Tang J,. 2007. Refractance window dehydration technology: A novel contact drying method. Drying Technol 25 (1): 37-48. (Pubitemid 46357940)
27. Nindo CI, Sun T, Wang S, Tang J, Powers J,. 2003. Evaluation of drying technologies for retention of physical quality and antioxidants in asparagus (Asparagus officinalis, L.). LWT-Food Sci Technol 36 (5): 507-516. (Pubitemid 36844420)
28. Suslow TV, Schroth MN,. 1981. Bacterial culture preservation in frozen and dry-film methylcellulose. Appl Environ Microbiol 42 (5): 872-877. (Pubitemid 12210937)
29. Flickinger MC, Schottel JL, Bond DR, Aksan A, Scriven L,. 2007. Painting and printing living bacteria: Engineering nanoporous biocatalytic coatings to preserve microbial viability and intensify reactivity. Biotechnol Prog 23 (1): 2-17. (Pubitemid 46293479)
30. Gialamas H, Zinoviadou KG, Biliaderis CG, Koutsoumanis KP,. 2010. Development of a novel bioactive packaging based on the incorporation of Lactobacillus sakei into sodium-caseinate films for controlling Listeria monocytogenes in foods. Food Res Int 43 (10): 2402-2408.
31. Barlow S, Biddle H, HAINES R, Smith K,. 2010. Process for providing a quantity of a particulate material. MIDDLESEX, UK; US20100068246.
32. Biddle H,. 2009. Case study: Printing powders with Sticky Web technology. Pharm Technol Euro 21 (11): 52.
33. Fu N, Chen XD,. 2011. Towards a maximal cell survival in convective thermal drying processes. Food Res Int 44 (5): 1127-1149.
34. García A,. 2011. Anhydrobiosis in bacteria: From physiology to applications. J Biosci 36 (5): 939-950.
35. Potts M, Slaughter SM, Hunneke F-U, Garst JF, Helm RF,. 2005. Desiccation tolerance of prokaryotes: Application of principles to human cells. Integ Com Biol 45 (5): 800-809. (Pubitemid 43098212)
36. Fry RM, Greaves RI,. 1951. The survival of bacteria during and after drying. J Hyg (Lond.) 49 (2-3): 220-246.
37. Rujivipat S, Bodmeier R,. 2010. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends. Eur J Pharm Biopharm 76 (3): 486-492.
38. Ohtake S, Martin RA, Saxena A, Lechuga-Ballesteros D, Santiago AE, Barry EM, Truong-Le V,. 2011. Formulation and stabilization of Francisella tularensis live vaccine strain. J Pharm Sci 100 (8): 3076-3087.
39. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE,. 2006. Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infect Dis 6 (6): 374-382. (Pubitemid 43737276)
40. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret J-F,. 2003. Experience with registered mucosal vaccines. Vaccine 21 (7-8): 678-683. (Pubitemid 36091978)
41. Janßen EM, Schliephacke R, Breitenbach A, Breitkreutz J,. 2013. Drug-printing by flexographic printing technology-A new manufacturing process for orodispersible films. Int J Pharm 441 (1-2): 818-825.
42. McConnell EL, Fadda HM, Basit AW,. 2008. Gut instincts: Explorations in intestinal physiology and drug delivery. Int J Pharm 364 (2): 213-226.